Patients with gout experienced no clinically significant urate-lowering effects from an 8-week course of a modest dosage of vitamin C (500 mg/day), despite the fact that plasma ascorbate levels increased, according to study findings published in Arthritis & Rheumatism (2013;65:1636-1642).
The study included 40 gout patients. Of these, 20 were randomized to receive an increased dose of allopurinol or to start taking vitamin C, and 20 were randomized to start treatment with allopurinol (100 m/day) or vitamin C.
Researchers observed no significant difference in serum urate or renal function between those who received vitamin C and those who did not.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.